Publication | Open Access
A Prospective, Multicenter, Phase 2 Study of Imatinib Mesylate in Korean Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumor
29
Citations
30
References
2009
Year
Imatinib is effective and safe in Korean patients with metastatic or unresectable GIST.
| Year | Citations | |
|---|---|---|
Page 1
Page 1